Your browser doesn't support javascript.
loading
A novel MRPS34 gene mutation with combined OXPHOS deficiency in an adult patient with Leigh syndrome.
Lenzini, L; Carecchio, M; Iori, E; Legati, A; Lamantea, E; Avogaro, A; Vitturi, N.
Afiliação
  • Lenzini L; University of Padova, Department of Medicine-DIMED, University Hospital, Padova, Italy.
  • Carecchio M; Movement Disorders Unit, Department of Neurosciences, University of Padova, Padova, Italy.
  • Iori E; University of Padova, Department of Medicine-DIMED, Division of Metabolic Diseases, University Hospital, Padova, Italy.
  • Legati A; Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20126 Milan, Italy.
  • Lamantea E; Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20126 Milan, Italy.
  • Avogaro A; University of Padova, Department of Medicine-DIMED, Division of Metabolic Diseases, University Hospital, Padova, Italy.
  • Vitturi N; University of Padova, Department of Medicine-DIMED, Division of Metabolic Diseases, University Hospital, Padova, Italy.
Mol Genet Metab Rep ; 30: 100830, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34938649
ABSTRACT
We report a novel pathogenic variant (c.223G > C; p.Gly75Arg) in the gene encoding the small mitoribosomal subunit protein mS34 in a long-surviving patient with Leigh Syndrome who was genetically diagnosed at age 34 years. The patient presented with delayed motor milestones and a stepwise motor deterioration during life, along with brain MRI alterations involving the subcortical white matter, deep grey nuclei and in particular the internal globi pallidi, that appeared calcified on CT scan. The novel variant is associated with a reduction of mS34 protein levels and of the OXPHOS complex I and IV subunits in peripheral blood mononuclear cells of the case. This study expands the number of variants that, by affecting the stability of the mitoribosome, may cause an OXPHOS deficiency in Leigh Syndrome and reports, for the first time, an unusual long survival in a patient with a homozygous MRPS34 pathogenic variant.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Genet Metab Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Genet Metab Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália